Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0072 | 0.9 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |